A dedicated discharge team, standardized education, a mandatory 24-hour room-in for caregivers, and appointments with a pharmacist are features that ensure a safe transition from hospital to home for ...

Amid the growing popularity of cannabis, it is perhaps not surprising that clinicians are increasingly accepting its use among cancer survivors,” the researchers wrote.

A higher NLR and rapid NLR shift between weeks 2 and 4 was strongly associated with RILD risk in patients with HCC.

To our knowledge, this is the first study that demonstrates a clinical advantage of proton therapy for NGGCT,” said David Y. Mak, MD.

Investigators compared early oncologic outcomes by staging modality among men diagnosed with very high-risk prostate cancer.

“Breast cancer survivors may have a slightly lower risk of AD compared with cancer-free individuals, potentially influenced by cancer treatments, underscoring the need for further research on ...

Many young adult survivors of childhood hematologic cancer do not have comprehensive survivorship care summaries or believe they need one.

Cancer patients without health insurance have not derived the same benefits from the introduction of ICIs as patients with private insurance.

Omitting carboplatin could be an efficacious de-escalated neoadjuvant strategy in the presence of dual HER2 blockade for patients with HER2-positive early breast cancer,” said Kun Wang, MD, PhD.

Lurbinectedin plus atezolizumab significantly reduced the risk of disease progression or death by 46% compared with atezolizumab alone.

Mild CMV reactivation was associated with beneficial effects, while severe cases required treatment, which increased the risk of toxicity and infections.

Updated thresholds outperform those recommended by American Thyroid Association guidelines for patients with medullary thyroid cancer.